blog

Small Molecules are Exciting Again with AI’s Help

Our experts have been closely watching the AI gold rush in biotech and think that it will lead to a boom in small molecule drug development.

Azeem Zeekrya, Director, Public Relations | March 27, 2024

Public Relations | Scientific Communication | AI | Biotech | Technology | Current Affairs

Biotech Moves Forward With Cautious Optimism

HDMZ’s in-depth analysis of the 2024 J.P. Morgan Healthcare Conference unveils trends — including pharma headwinds, AI and Wegovy — that will shape the life science industry this year.

John Kang, Senior Vice President, Public Relations | January 16, 2024

AI | Biotech | Conferences & Events

Chicago, Chicago, That Biotech Town

Last month, a Chicago-based biotech company called CellTrans was on the receiving end of a remarkable regulatory milestone: The company received FDA approval for the first cellular therapy for Type-1 diabetes.

Dillon Allie, President & CEO | July 19, 2023

Biotech | Life Sciences

With Major Government Support, Biotech and Life Sciences Likely Heading Into Innovation Renaissance

Read this week’s blog post to see how Biden’s new executive order may spark biotech, healthcare and life sciences innovations and startups.

Azeem Zeekrya, Associate Director, Scientific Communications | October 24, 2022

Biotech | Life Sciences | Current Affairs

Zoomedia & Harris D. McKinney Join Forces

For the last 16 years, Zoomedia has been leading interactive communications for the life sciences. Today, we are delighted to announce that we have joined forces with Harris D. McKinney, a leading life science marketing and brand communications agency.

Barbara Lavery | June 11, 2014

Marketing | Press Releases | Public Relations | Scientific Communication | HDMZ | Biotech | Life Sciences | Website Development

Deliver a Successful Investor Presentation

Does your investor presentation clearly articulate your passion, commitment and value in 20 minutes or less? The development and delivery of a presentation plays a critical part in getting the attention you want and deserve. Every company has a different story to tell, but most of the time the presentations are in the same format, in the same room, and to the same people. Our team has had the privilege of watching and developing biotech company presentations for over 15 years.

HDMZ Staff | March 25, 2013

Corporate Communications | Biotech | Pharma | Investor Presentations | Investor Relations

Networked & Personalized - the future of biotech?

During BIO2012 last week, Ernst & Young presented their annual Beyond Borders report on the state of the biotech industry. Several themes are covered in the report but the underlying trend is a much broader discussion and movement towards open sharing of data and collaboration across academia, industry, patient advocacy groups and payors. This "networked innovation" aligns biotech with high tech's much broader use of data and personalized targeting that we see at work in social networks and online advertising every day and has enormous opportunity to increase timelines and success rates in drug development.

Barbara Lavery | June 25, 2012

Biotech | Personalized Medicine | Pharma

Spring time = launch time!

With FDA and EMA reviews and decisions pending for many of our clients we are working on global launch strategies to support commercial and corporate teams as they gear up for product approval across multiple countries.

Barbara Lavery | April 03, 2012

Communication Plan | Biotech | Pharma | Social Media | Website Development